Aims Diabetic peripheral neuropathy (DPN) occurs in about half of people with diabetes, of
whom a quarter may develop chronic pain. Pain may remain for years yet be difficult to treat …

Background Neuropathic pain is a clinically relevant adverse effect of several anticancer
drugs that markedly impairs patients' quality of life and frequently leads to dose reduction or …

Diabetic neuropathy is among the most frequent complications of both type 1 (T1DM) and
type 2 diabetes (T2DM) and commonly manifests as a distal symmetrical polyneuropathy …

Chemotherapy-induced neuropathic pain (CINP) is a common adverse health related
comorbidity that manifests later in life in paediatric cancer patients. Current analgesia is …

Cisplatin-based chemotherapy is a common treatment for paediatric cancer. Unfortunately,
cisplatin treatment causes neuropathic pain, a highly prevalent adverse health related …

Diabetic neuropathy is an important long-term complication of diabetes. This study explored
the hypothesis that hydrogen sulfide (H2S) ameliorates neuropathic pain by controlling …

Neuropathic pain, such as that seen in diabetes mellitus, results in part from central
sensitisation in the dorsal horn. However, the mechanisms responsible for such sensitisation …

Aberrant, neovascular retinal blood vessel growth is a vision-threatening complication in
ischemic retinal diseases. It is driven by retinal hypoxia frequently caused by capillary …

Objective The gold standard for measuring blood‐retinal barrier permeability is the Evans
blue assay. However, this technique has limitations in vivo, including non‐specific tissue …

Study Design: Retrospective multicenter study. Objectives: To evaluate the surgical
outcomes of cervical ossification of the posterior longitudinal ligament (OPLL) in diabetes …